Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma
about
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways.Cancer-type dependent expression of CK2 transcripts.miR-217-casein kinase-2 cross talk regulates ERK activation in ganglioglioma.Second-generation CK2α inhibitors targeting the αD pocket.Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates
P2860
Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Protein Kinase CK2α Maintains ...... ot ERK in BRAF Mutant Melanoma
@en
type
label
Protein Kinase CK2α Maintains ...... ot ERK in BRAF Mutant Melanoma
@en
prefLabel
Protein Kinase CK2α Maintains ...... ot ERK in BRAF Mutant Melanoma
@en
P2093
P2860
P356
P1476
Protein Kinase CK2α Maintains ...... ot ERK in BRAF Mutant Melanoma
@en
P2093
Adrienne D Cox
Bingying Zhou
Channing J Der
Daniel A Ritt
Deborah K Morrison
P2860
P304
17804-17815
P356
10.1074/JBC.M115.712885
P407
P577
2016-05-17T00:00:00Z